Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brimonidine for Dry Eye Disease
NCT03418727Phase 2Completed
- Sponsor
- Ocugen
- Start
- Sep 2017
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of brimonidine tartrate + sodium hyaluronate in dry eye disease (DED), sponsored by Ocugen. Started Sep 2017; status: completed.
02
Drugs
brimonidine tartrate + sodium hyaluronate
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT03418727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03418727.